La lista delle pubblicazioni scientifiche che mi vedono come autore
, 2024. Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by dupilumab. Ann Allergy Asthma Immunol 132(1):69-75 , 2023. Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study. Laryngoscope. , 2023. Statistical advice provided by ChatGPT regarding an accepted article in Allergy. Allergy. , 2023. Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders. Biomedicines 11. , 2023. Editorial comment on "Environmental influences on childhood asthma: Climate change". Pediatr Allergy Immunol 34(8):e14011 , 2023. Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control. Respir Med 218:107391 , 2023. Advancing precision medicine in asthma: Evolution of treatment outcomes. J Allergy Clin Immunol 152(4):835-840 , 2023. Editorial: pharmacotherapy and evidence-based medicine section. Curr Opin Allergy Clin Immunol 23(4):307-308 , 2023. Real-world data: A relevant component in the framework of scientific evidence. Asia Pac Allergy 13(1):40-43 , 2023. COPD and biologic treatment: state of the art. Curr Opin Allergy Clin Immunol 23(4):309-318 , 2023. Mast Cells in Upper and Lower Airway Diseases: Sentinels in the Front Line. Int J Mol Sci 24. , 2023. Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines. Vaccines (Basel) 11. , 2023. Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions. Vaccines (Basel) 11. , 2023. The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital. Vaccines (Basel) 11. , 2023. Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation. J Pers Med 13. , 2023. Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era. J Pers Med 13. , 2023. Evolution in Endoscopic Sinus Surgery: The Adjuvant Role of Reboot Surgery in Patients with Uncontrolled Nasal Symptoms of Eosinophilic Granulomatosis with Polyangiitis. J Pers Med 13. , 2023. Care for Patients with Type-2 Chronic Rhinosinusitis. J Pers Med 13. , 2023. Use, Abuse, and Misuse of Nasal Medications: Real-Life Survey on Community Pharmacist's Perceptions. J Pers Med 13. , 2023. Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate. Expert Rev Clin Immunol 19(6):575-584 , 2023. Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy. Clin Exp Allergy 53(6):610-625 , 2023. Exhaled nitric oxide in asthma: from diagnosis to management. Curr Opin Allergy Clin Immunol 23(1):29-35 , 2023. Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity. Int Arch Allergy Immunol 184(1):12-20 , 2023. Outcomes of Non-Mucosa Sparing Endoscopic Sinus Surgery (Partial Reboot) in Refractory Chronic Rhinosinusitis with Nasal Polyposis: An Academic Hospital Experience. Laryngoscope 133(7):1584-1589 , 2023. Middle meatus nasal cytology compared to inferior turbinate cytology in non allergic rhinitis. Eur Arch Otorhinolaryngol 280(2):913-918 , 2022. Cross-Cultural Validation of the Short Version of the Questionnaire of Olfactory Disorders-Negative Statements into Italian: Towards Personalized Patient Care. J Pers Med 12. , 2022. Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps. World Allergy Organ J 15(11):100700 , 2022. Critical evaluation of asthma biomarkers in clinical practice. Front Med (Lausanne) 9:969243 , 2022. Biologics and airway remodeling in severe asthma. Allergy 77(12):3538-3552 , 2022. Current treatment strategies for seasonal allergic rhinitis: where are we heading? Clin Mol Allergy 20(1):9 , 2022. Editorial: Pharmacotherapy and evidence based medicine. Curr Opin Allergy Clin Immunol 22(4):257-258 , 2022. Severe asthma and personalized approach in the choice of biologic. Curr Opin Allergy Clin Immunol 22(4):268-275 , 2022. Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol 12(12):1562-1565 , 2022. Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas. Clin Transl Allergy 12(6):e12144 , 2022. Biologics in severe asthma: the role of real-world evidence from registries. Eur Respir Rev 31. , 2022. New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine. Vaccines (Basel) 10. , 2022. The Present and Future of Allergen Immunotherapy in Personalized Medicine. J Pers Med 12. , 2022. Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps. Healthcare (Basel) 10. , 2022. Impact of asthma on bronchiectasis severity and risk of exacerbations. J Asthma 59(3):469-475 , 2021. Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets. Front Physiol 12:815842 , 2021. Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis. Clin Transl Allergy 11(4):e12033 , 2021. Diagnostic delay and misdiagnosis in eosinophilic oesophagitis. Dig Liver Dis 53(12):1632-1639 , 2021. Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital. World Allergy Organ J 14(5):100541 , 2021. Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? Allergy 76(3):961-962 , 2021. Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence". Allergy 76(9):2663-2672 , 2021. Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI. Allergy Asthma Immunol Res 13(2):219-228 , 2021. Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists. Int J Clin Pharm 43(3):708-715 , 2021. Gastroesophageal reflux and asthma: when, how, and why. Curr Opin Allergy Clin Immunol 21(1):52-58 , 2021. Allergen immunotherapy and biologics in respiratory allergy: friends or foes? Curr Opin Allergy Clin Immunol 21(1):16-23 , 2021. Alpha1-antitrypsin deficiency and asthma. Curr Opin Allergy Clin Immunol 21(1):46-51 , 2021. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry. Expert Rev Respir Med 15(3):419-424 , 2021. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments. Allergy 76(3):887-892 , 2020. Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma. Respir Med 174:106199 , 2020. Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma. J Breath Res 15(1):016007 , 2020. Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis. J Allergy Clin Immunol Pract 8(10):3587-3589 , 2020. Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model. Clin Transl Allergy 10:23 , 2020. Do the current guidelines for asthma pharmacotherapy encourage over-treatment? Expert Opin Pharmacother 21(11):1283-1286 , 2020. An academic allergy unit during COVID-19 pandemic in Italy. J Allergy Clin Immunol 146(1):227 , 2020. Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC). Multidiscip Respir Med 15(1):36 , 2020. Vaping effects on asthma: results from a web survey and clinical investigation. Intern Emerg Med 15(4):663-671 , 2020. The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life. Allergy 75(6):1460-1463 , 2019. Interleukin-5 in the Pathophysiology of Severe Asthma. Front Physiol 10:1514 , 2019. Immunostimulants in respiratory diseases: focus on Pidotimod. Multidiscip Respir Med 14:31 , 2019. One year of mepolizumab. Efficacy and safety in real-life in Italy. Pulm Pharmacol Ther 58:101836 , 2019. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. Eur J Intern Med 68:e7-e11 , 2019. Real-life studies of biologics used in asthma patients: key differences and similarities to trials. Expert Rev Clin Immunol 15(9):951-958 , 2019. Asthma from immune pathogenesis to precision medicine. Semin Immunol 46:101294 , 2019. Treatable traits in chronic rhinosinusitis with nasal polyps. Curr Opin Allergy Clin Immunol 19(4):373-378 , 2019. New drugs in early-stage clinical trials for allergic rhinitis. Expert Opin Investig Drugs 28(3):267-273 Publication list retrieved from NCBI using ImpactPubs
